Abstract
Objective This systematic review aims to synthesize current knowledge on Propylene Oxide (PO) in human exhaled breath, examining its presence across various biological matrices and exploring methodologies for its analysis. It seeks to elucidate the sources of PO in the human body and understand individual variability in detoxification processes.
Methods A comprehensive literature search was conducted across 12 databases and specialized repositories, spanning over 10,000 publications without language restrictions until February 2024. Seventeen AI tools were employed to enhance study identification and analysis, focusing on both direct mentions and indirect evidence of PO behavior and detection in the human body. Assessment tools for risk of bias included SYRCLE’s tool for animal studies, the Newcastle-Ottawa Scale for cohort and case-control studies, and the ROBINS-I tool for non-randomized studies. The selection process yielded 88 studies, encompassing a range of research types and species, supplemented by reviews, monographs, and editorials to provide a comprehensive overview.
Results The search revealed limited direct evidence on PO concentrations in exhaled breath, with only one reference providing concrete data (0.083 ppb to 0.3 ppb). However, numerous references offered indirect insights into PO’s persistence and detection in the human body, particularly in blood and urine. The review highlights the enzymes involved in PO metabolism, the evolution of analytical methodologies, and the challenges and potentials of employing AI tools in systematic reviews.
Conclusions The scarcity of direct evidence on PO in exhaled breath underscores a significant gap in the literature and existing databases. Directly and indirectly relevant sources indicate variability in environmental compound concentrations influenced by genetics, health status, metabolism, and the microbiome. The review emphasizes the difficulties in synthesizing data on PO effects due to heterogeneous inputs and complex exposure scenarios. It underscores the need for advanced AI capabilities in literature reviews to capture nuanced, indirect evidence more effectively and calls for targeted research and technological innovation in environmental health sciences. This study advocates for the strategic enhancement of AI tools to navigate scientific literature with greater efficacy, leveraging PRISMA guidelines and diverse data sources to minimize bias and enhance reliability.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=397159
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Protocol: PROSPERO 2023 CRD42023397159
Data: available at https://osf.io/w7682/via The Open Science Framework
Abbreviations
- 2-HPMA
- N-acetyl-S-(2-hydroxypropyl)cysteine, mercapturic acids derived from propylene oxide
- ADH
- Alcohol dehydrogenase
- AEGL
- Acute Exposure Guideline Levels developed by EPA
- AI
- Artificial Intelligence
- ALDH
- Aldehyde dehydrogenase
- CYPs
- Cytochromes P450, involved in the metabolism of xenobiotics in the body
- CYP2E1
- Cytochrome P450 2E1, a member of the cytochrome P450 mixed-function oxidase system
- EH
- epoxide hydrolase, also known as mEH
- EPA
- the Environmental Protection Agency
- FMO
- flavin-containing monooxygenase enzyme family
- GST
- Glutathione S-transferase family
- IARC
- International Agency for Research on Cancer
- LC50
- median lethal concentration in air that can kill 50% of a test population
- LD50
- median lethal dose that can kill 50% of a test population
- LOA
- Level of Distinct Odor Awareness
- mEH
- microsomal epoxide hydrolase
- MeSH
- Medical Subject Headings, a controlled and hierarchically-organized vocabulary produced by NLM
- NLM
- the National Library of Medicine
- NPSH
- nonprotein sulfhydryl (SH-groups)
- OSF
- Open Science Framework, a platform for data sharing and collaboration
- PPB
- parts per billion
- PPBV
- parts per billion by volume, specifically refers to the concentration of a substance in a gaseous mixture
- PPM
- parts per million
- PPMV
- parts per million by volume
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- PE
- Propylene
- PG
- Propylene Glycol
- PO
- Propylene Oxide
- RNM
- respiratory nasal mucosa
- RQ
- Research Question
- SCE
- sister chromatid exchanges
- SMR
- standardized mortality ratio
- SSB
- DNA single-strand breaks
- TWA
- time weighted average
- URT
- upper respiratory tract
- US EPA
- US Environmental Protection Agency
- VOSviewer
- “Visualization of Similarities Viewer” – a software tool developed for constructing and visualizing scientific landscapes
